Face washing promotion for preventing active trachoma
- PMID: 25697765
- PMCID: PMC4441394
- DOI: 10.1002/14651858.CD003659.pub4
Face washing promotion for preventing active trachoma
Abstract
Background: Trachoma remains a major cause of avoidable blindness among underprivileged populations in many developing countries. It is estimated that about 146 million people have active trachoma and nearly six million people are blind due to complications associated with repeat infections.
Objectives: The objective of this review was to assess the effects of face washing promotion for the prevention of active trachoma in endemic communities.
Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2015, Issue 1), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to January 2015), EMBASE (January 1980 to January 2015), PubMed (January 1948 to January 2015), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to January 2015), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com) (accessed 10 January 2014), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 26 January 2015.To identify further relevant trials we checked the reference lists of the included trials. Also, we used the Science Citation Index to search for references to publications that cited the trials included in the review. We contacted investigators and experts in the field to identify additional trials.
Selection criteria: We included randomized controlled trials (RCTs) or quasi-RCTs that compared face washing with no treatment or face washing combined with antibiotics against antibiotics alone. Trial participants were residents of endemic trachoma communities.
Data collection and analysis: Two review authors independently extracted data and assessed trial quality. We contacted trial authors for additional information when needed. Two trials met our inclusion criteria; but we did not conduct meta-analysis due to methodological heterogeneity.
Main results: We included two cluster-RCTs, which provided data from 2447 participants. Both trials were conducted in areas endemic to trachoma: Northern Australia and Tanzania. The follow-up period was three months in one trial and 12 months in the other; both trials had about 90% participant follow-up at final visit. Overall the quality of the evidence is uncertain due to the trials not reporting many design methods and the differences in outcomes reported between trials.Face washing combined with topical tetracycline was compared with topical tetracycline alone in three pairs of villages in one trial. The trial found that face washing combined with topical tetracycline reduced 'severe' active trachoma compared with topical tetracycline alone at 12 months (adjusted odds ratio (OR) 0.62, 95% confidence interval (CI) 0.40 to 0.97); however, the trial did not find any important difference between the intervention and control villages in reducing other types of active trachoma (adjusted OR 0.81, 95% CI 0.42 to 1.59). Intervention villages had a higher prevalence of clean faces than the control villages among children with severe trachoma (adjusted OR 0.35, 95% CI 0.21 to 0.59) and any trachoma (adjusted OR 0.58, 95% CI 0.47 to 0.72) at 12 months follow-up. The second trial compared eye washing to no treatment or to topical tetracycline alone or to a combination of eye washing and tetracycline drops in children with follicular trachoma. At three months, the trial found no evidence of benefit of eye washing alone or in combination with tetracycline eye drops in reducing follicular trachoma amongst children with follicular trachoma (risk ratio (RR) 1.03, 95% CI 0.96 to 1.11; one trial, 1143 participants).
Authors' conclusions: There is evidence from one trial that face washing combined with topical tetracycline may be effective in reducing severe active trachoma and in increasing the prevalence of clean faces at one year follow-up. Current evidence is inconclusive as to the effectiveness of face washing alone or in combination with topical tetracycline in reducing active or severe trachoma.
Conflict of interest statement
HE: none known. MA: none known. MR: none known.
Figures
Update of
-
Face washing promotion for preventing active trachoma.Cochrane Database Syst Rev. 2012 Apr 18;4(4):CD003659. doi: 10.1002/14651858.CD003659.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Feb 20;(2):CD003659. doi: 10.1002/14651858.CD003659.pub4. PMID: 22513915 Free PMC article. Updated.
References
References to studies included in this review
Peach 1987 {published data only}
-
- Peach H, Piper S, Devanesen D, Dixon B, Jefferies C, Braun P, et al. Northern Territory Trachoma Control and Eye Health Committee's Randomised Controlled Trial of the Effect of Eye Drops and Eye Washing on Follicular Trachoma Among Aboriginal Children. Report of the Northern Territory Trachoma Control and Eye Health Committee Incorporated 1987:1‐33.
West 1995 {published data only}
-
- West S, Lynch M. Protective effect of face‐washing against trachoma in Tanzania. Investigative Ophthalmology and Visual Science 1993:ARVO E‐Abstract 2915.
-
- West S, Muñoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BB, et al. Impact of face‐washing on trachoma in Kongwa, Tanzania. Lancet 1995;345(8943):155‐8. - PubMed
-
- West SK, Muñoz B, Lynch M, Kayongoya A, Mmbaga BB, Taylor HR. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. American Journal of Epidemiology 1996;143(1):73‐8. - PubMed
References to studies excluded from this review
Edwards 2006 {published data only}
-
- Edwards T, Cumberland P, Hailu G, Todd J. Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia. Ophthalmology 2006;113(4):548‐55. - PubMed
Khandekar 2005 {published data only}
-
- Khandekar R, Mabry R, Al Hadrami K, Sarvanan N. Active trachoma, face washing (F) and environmental improvement (E) in a high‐risk population in Oman. Eastern Mediterranean Health Journal 2005;11(3):402‐9. - PubMed
Khandekar 2006 {published data only}
-
- Khandekar R, Ton TK, Do Thi P. Impact of face washing and environmental improvement on reduction of active trachoma in Vietnam‐a public health intervention study. Ophthalmic Epidemiology 2006;13(1):43‐52. - PubMed
King 2011 {published data only}
-
- King JD, Ngondi J, Kasten J, Diallo MO, Zhu M, Cromwell EA, et al. Randomised trial of face‐washing to develop a standard definition of a clean face for monitoring trachoma control programmes. Transactions of the Royal Society of Tropical Medicine and Hygiene 2011;105(1):7‐16. - PubMed
Rubinstein 2006 {published data only}
-
- Rubinstein RA, Lane SD, Sallam SA, Sheta AS, Gad ZM, Sherif AR, et al. Controlling blinding trachoma in the Egyptian Delta: Integrating clinical, epidemiological and anthropological understandings. Anthropology & Medicine 2006;13(2):99‐118. - PubMed
Sutter 1983 {published data only}
-
- Sutter E, Ballard R. Community participation in the control of trachoma in Gazankulu. Social Science and Medicine 1983;17(22):1813‐7. - PubMed
References to studies awaiting assessment
NCT00348478 {unpublished data only}
-
- NCT00348478. Impact of water and health education programs on trachoma and ocular C. trachomatis in Niger. clinicaltrials.gov/ct2/show/NCT00348478 (accessed 19 February 2014).
Additional references
Bailey 2001
Emerson 2000
-
- Emerson PM, Cairncross S, Bailey RL, Mabey DCW. Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control. Tropical Medicine & International Health 2000;5(8):515‐27. - PubMed
Evans 2011
Glanville 2006
Higgins 2011
-
- Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
ICEH 1999
-
- International Centre for Eye Health. Slides/Text Teaching Series: No. 7 Trachoma. 2nd Edition. London: International Centre for Eye Health, 1999.
Pruss 2000
Rabiu 2012
-
- Rabiu M, Alhassan M, Ejere H, Evans JR. Environmental sanitary interventions for preventing active trachoma. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004003.pub4] - DOI
RevMan 2014 [Computer program]
-
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Stocks 2014
Thylefors 1987
West 1991
-
- West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. International Journal of Epidemiology 1991;20(4):1088‐92. - PubMed
WHO 1997a
-
- World Health Organization. Blindness and Visual Disability. Part II of VII: Major Causes Worldwide. Fact sheet N 143. 1997. www.who.int/inf‐fs/en/fact143.html (accessed 13 September 2001).
WHO 1997b
-
- World Health Organization. Future approaches to trachoma control, report of a global scientific meeting; 1996 June 17‐20; Geneva. WHO//PBL/96.56 1997:1‐44.
WHO 2001
-
- Négrel AD, Taylor HR, West S. Guidelines for the Rapid Assessment for Blinding Trachoma. WHO/PBD/GET/00.8 2001:1‐71.
WHO 2011
-
- World Health Organization. Report of the Fifteenth Meeting of the WHO Alliance for the Global Elimination of Trachoma By 2020; 2011 April 18‐20; Geneva. http://trachoma.org/sites/default/files/guidesandmanuals/GET15REPORT4.pdf (accessed 7 July 2014):1‐46.
References to other published versions of this review
Ejere 2002
Ejere 2004
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
